Evidence-Based Design Concepts and the Business Case
The core concept
Evidence-based design (EBD) is the deliberate use of the best available credible evidence, filtered through professional judgment, to inform design decisions - followed by measurement of the results. It is a process, not a style: two buildings that look nothing alike can both be rigorous EBD projects. A widely cited definition is Stichler and Hamilton's: basing decisions about the built environment on credible research to achieve the best possible outcomes.
Concepts to know
- Evidence hierarchy: systematic reviews and meta-analyses at the top, then randomized controlled trials, quasi-experimental studies, non-experimental and case studies, and expert opinion or anecdote at the bottom. The hierarchy is a starting point, not a verdict - a study's quality and applicability matter as much as its design.
- Hypothesis-driven thinking: every design decision is an implicit cause-and-effect assumption ("single rooms will reduce cross-transmission") that can be stated, tested, and later measured.
- Outcome families: patient safety, clinical outcomes, patient experience, staff outcomes (satisfaction, retention, injury), operational efficiency, and financial performance.
The business case
Capital is justified on lifecycle value, not first cost. Common benefit streams include fewer patient falls, fewer hospital-acquired infections (private and acuity-adaptable rooms), reduced medication errors and transfers, shorter length of stay, improved staff retention with lower recruitment and orientation costs, and reduced noise-related sleep disruption. The trap: questions often imply EBD proves a universal return on investment. It does not - returns are project-specific and must be modeled with local volumes, costs, and assumptions; benefits also depend on operational change, not design alone.
Rule of thumb
Convert every claimed benefit into the language of finance: expected reduction × baseline events per year × cost per event = annual benefit; compare that to the incremental capital cost to derive a payback period.